http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-S60197623-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_324beb8b942a3a6ed1f1f576bcd76c45 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-19 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-14 |
filingDate | 1984-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e17f641fd79c9f77b3c3029b19d3bbca |
publicationDate | 1985-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | JP-S60197623-A |
titleOfInvention | Urine-alkalizing composition |
abstract | PURPOSE: The titled composition that contains citric acid, sodium citrate and potassium chloride in a specific proportion, thus being free from deliquescence without causing imbalance of Na + /K + in blood and used as a remedy for hyperuricacidemia in hypertension. n CONSTITUTION: The objective composition is obtained by allowing a mixture of citric acid, sodium citrate and potassium chloide in a proportion of x:y:z (in moles) to be included by 80W100wt% concentration where x, y and z are in ranges of 0.4≤x≤1.4, 1.2≤y≤4.0 and 1.0≤z≤12.0, respectively. Especially, the composition where 0.8≤x≤1.1, 1.8≤y≤2.2 and 2.8≤z≤3.2 is preferred. The composition improves its deliquescence and alkalize the urine without causing imbalance in Na + /K + to increase the solubility of uric acid. It also increases the excretion of uric acid and urinary amount. n COPYRIGHT: (C)1985,JPO&Japio |
isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109430667-A |
priorityDate | 1984-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 27.